PET/CT helps detect sign of hypertrophic cardiomyopathy

03/21/2012 | MolecularImaging.net

A study published in the Journal of Nuclear Medicine found that maximal wall thickness measured through PET/CT can be a strong indicator of hypertrophic cardiomyopathy. Maximal wall thickness was linked to impaired peak myocardial blood flow and myocardial flow reserve. The researchers said they did not find a link between left ventricular outflow tract gradients and myocardial blood flow. The results need to be validated in larger trials, the researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA